Logo image of DRUG

BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Earnings & Estimates

USA - NASDAQ:DRUG - CA10919W4056 - Common Stock

66.4 USD
-1.64 (-2.41%)
Last: 10/16/2025, 8:00:01 PM
66.4 USD
0 (0%)
After Hours: 10/16/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
DRUG revenue by date.DRUG revenue by date.
EBITDA
YoY % growth
DRUG ebitda by date.DRUG ebitda by date.
N/AN/AN/A-14.967M-7.294M
51.26%		-2.74M
62.43%
EBIT
YoY % growth
DRUG ebit by date.DRUG ebit by date.
-78.7K-480.4K
-510.42%		-8.805M
-1,732.83%		-14.973M
-70.05%		-7.367M
50.80%		-2.814M
61.80%
Operating Margin
DRUG operating margin by date.DRUG operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DRUG eps by date.DRUG eps by date.
N/AN/AN/AN/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A